Opus Genetics (IRD) Stock Chart & Stock Price History $0.98 -0.04 (-4.25%) Closing price 06/27/2025 04:00 PM EasternExtended Trading$0.96 -0.01 (-1.19%) As of 06/27/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsTrendsBuy This Stock Opus Genetics Stock Price Performance The Opus Genetics (IRD) stock chart highlights key performance trends across multiple timeframes. Since the beginning of the year, the stock decreased 17.93%. In the past month, the stock has decreased 2.66%, reflecting recent market activity. As of the latest close, Opus Genetics traded at $0.98 with a market cap of $58.26 million and volume of 783,289 shares. Receive IRD Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Opus Genetics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+0.66%1 Month Performance-2.66%3 Month Performance-3.31%Year-To-Date Performance-17.93% IRD Stock Chart for Monday, June, 30, 2025 IRD Chart by TradingView Opus Genetics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization06/27/2025$1.02$0.98-4.25%$1.03$0.97783,289 shs$58.26 million06/26/2025$0.97$1.02+5.13%$1.05$0.969.50 million shs$60.85 million06/25/2025$0.92$0.97+5.06%$0.98$0.92232,165 shs$57.88 million06/24/2025$0.91$0.92+1.91%$0.96$0.91114,445 shs$55.10 million06/23/2025$0.95$0.91-4.62%$0.97$0.91272,203 shs$54.06 million06/20/2025$0.93$0.95+2.16%$0.97$0.93164,097 shs$56.68 million06/19/2025$0.93$0.93$0.96$0.91184,159 shs$55.48 million06/18/2025$0.92$0.93+0.69%$0.96$0.91184,159 shs$55.48 million06/17/2025$0.94$0.92-1.88%$0.98$0.92310,465 shs$55.10 million06/16/2025$0.97$0.94-2.96%$0.97$0.93223,549 shs$56.16 million Get the Latest News and Ratings for IRD and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Opus Genetics and its competitors with MarketBeat's FREE daily newsletter. 06/13/2025$0.99$0.97-2.18%$1.00$0.96249,802 shs$57.87 million06/12/2025$0.99$0.99+0.07%$1.00$0.95196,044 shs$59.16 million06/11/2025$1.02$0.99-2.85%$1.05$0.98266,309 shs$59.12 million06/10/2025$1.05$1.02-2.86%$1.05$1.02406,150 shs$60.85 million06/09/2025$1.04$1.05+0.96%$1.08$1.00479,934 shs$62.64 million06/06/2025$1.00$1.04+4.00%$1.10$0.96706,620 shs$62.05 million06/05/2025$0.99$1.00+1.01%$1.05$0.93752,182 shs$59.66 million06/04/2025$1.01$0.99-1.98%$1.08$0.99751,728 shs$59.06 million06/03/2025$1.09$1.01-7.34%$1.09$0.991.67 million shs$60.26 million06/02/2025$1.00$1.09+8.64%$1.75$1.0540.13 million shs$65.03 million05/30/2025$0.99$1.00+0.88%$1.04$0.9873,087 shs$59.86 million05/29/2025$1.01$0.99-1.04%$1.03$0.95204,035 shs$59.33 million Related Companies Semper Paratus Acquisition Stock Price Chart biote Stock Price Chart Inhibrx Biosciences Stock Price Chart Design Therapeutics Stock Price Chart Esperion Therapeutics Stock Price Chart Nanobiotix Stock Price Chart MediWound Stock Price Chart Cardiff Oncology Stock Price Chart I-Mab Stock Price Chart ProQR Therapeutics Stock Price Chart Receive IRD Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Opus Genetics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:IRD) was last updated on 6/30/2025 by MarketBeat.com Staff From Our PartnersCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredAI Meltdown Imminent: Dump These Stocks Now!If you have any money in the markets, especially in AI stocks… Please click here to see Elon Musk’s new inv...Paradigm Press | Sponsored“Trump’s 24-Hour Profit Windows” revealedTrading legend Larry Benedict has discovered a repeating surge of $240 billion (and more)... Flowing into a...Brownstone Research | SponsoredSpecial gold investment soars 2,300% ... 5,090% ... 9,850%In my 54 years as an investor, I’ve seen my share of gold bull markets. But nothing comes close to the rall...Weiss Ratings | Sponsored379 passengers walked away from thisElon Musk just wrote a $51 million check to back this material’s next phase… Because it’s not just saving l...True Market Insiders | SponsoredA grave, grave error.Famed financial analyst, Porter Stansberry, calls this technology “The Final Frontier” because it holds the ke...Porter & Company | SponsoredCollect $7k per month from Tesla’s SECRET dividendI just uncovered a strategy that could pay out up to $7,013 every month—without needing a traditional dividend...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Opus Genetics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Opus Genetics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free IRD Stock Alerts